Literature DB >> 33969038

Multidrug Resistance of Escherichia coli Strains Isolated From Bovine Feces and Carcasses in Northeast Mexico.

Ana V Martínez-Vázquez1, Jose Vázquez-Villanueva2, Luis M Leyva-Zapata2, Hugo Barrios-García2, Gildardo Rivera1, Virgilio Bocanegra-García1.   

Abstract

In this work, the antimicrobial resistance profile of Escherichia coli strains (n = 248) isolated from bovine feces and carcass samples from Tamaulipas, Mexico, was evaluated. Susceptibility to 12 antibiotics conventionally used in human and veterinary treatments was determined according to Clinical and Laboratory Standards Institute guidelines. Genes encoding resistance to tetracycline (tetA and tetB), streptomycin (strA), aminoglycoside (aadA), and β-lactamase (bla TEM and bla SHV) were investigated by PCR. Also, stx1, stx2, eae, bfp, and hlyA encoding virulence factors were determined. Of the isolates, 85.9% were confirmed as E. coli strains. Among the 213 E. coli isolates tested, 94.8% (202/213) showed resistance for at least one antimicrobial, mainly ampicillin (83.0%; 177/213), cephalothin (76.0%; 162/213), and tetracyclines (69.0%; 147/213). In all the other antibiotics tested, the resistance percentage was below 36%. A multidrug-resistant phenotype was found in 72.7% of the tested strains. The presence of the tet gene (tetA or tetB) was detected in 43.1% of the isolates, the strA gene in 17.3%, and aadA1 in 51.6%. The bla TEM and bla SHV genes were found in 10.3 and 0.4% of the isolates, respectively. stx1 was detected in 4.2% of isolates, stx2 in 7.0, and hlyA in 2.8%. The virulence genes, eae and bfp, were not detected in any strain. These results indicate that Tamaulipas food products of bovine origin can be a source of multiresistant E. coli strains for the environment and exposure for consumers.
Copyright © 2021 Martínez-Vázquez, Vázquez-Villanueva, Leyva-Zapata, Barrios-García, Rivera and Bocanegra-García.

Entities:  

Keywords:  ESBL; Escherichia coli; MDR; antimicrobial resistance; bovine

Year:  2021        PMID: 33969038      PMCID: PMC8102688          DOI: 10.3389/fvets.2021.643802

Source DB:  PubMed          Journal:  Front Vet Sci        ISSN: 2297-1769


Introduction

Antimicrobial resistance (AMR) is a complex multifactorial process driven by numerous and varied factors (1). A causal relationship has been demonstrated with the increased use of antimicrobials in veterinary medicine for treating and preventing disease and for growth promotion (2). Antibiotic-resistant bacteria can be transferred directly from animals to humans and can spread to the soil, food, and groundwater by the application of manure to agricultural fields (3–5). The emergence of AMR in food-producing animals is of concern since these zoonotic bacteria pose a risk to human health via the food chain (6, 7). Resistant proportions in the sentinel organism Escherichia coli are often referred to as “prevalence” of resistance (8). E. coli is known as a dangerous pathogen to human health. It contributes to the dissemination of AMR, and it is a good indicator of transmission pathways because it is ubiquitous, shares the same niche as other enteric pathogens, and can be transferred by the same route (7, 9, 10). E. coli strains can colonize cattle at any age (11), and bovine carriers are often asymptomatic. Consequently, these enteric pathogens, when shed in the feces, are a source of contamination of water and food products (12). Analysis of antibiotic resistance in microbial isolates from agricultural and other environments could help us recognize resistance gene reservoirs that may be present in bacterial populations associated with food production animals (13). Monitoring of AMR in E. coli may provide information on antimicrobial abuse and the dynamics of transmission and development of AMR pathogens. Only a few reports from México about the AMR profiles of E. coli isolates in food-producing animals are available. Amezquita et al. (14), in northwestern Mexico, examined the AMR profiles of Shiga toxin-producing E. coli (STEC) O157 and non-O157 from cattle, sheep, and poultry. Multidrug resistance profiles were identified in 42% of the non-susceptible STEC strains. However, in northeast Mexico, no information has been generated regarding the possible multidrug resistance in cattle (feces or carcasses) and its potential risk for human health. The objective of this work was to investigate the AMR profile in E. coli isolated from cattle in northeast Mexico.

Materials and Methods

Sample Collection

Samples were collected from 124 cattle from a bovine slaughterhouse located in the center of the state of Tamaulipas, Mexico. This slaughterhouse receives cattle from nearby municipalities. One specimen was randomly selected per farm for the fecal sample and the carcass sample later to be taken.

Fecal Samples

A total of 124 bovine fecal samples were collected by direct rectal retrieval using disposable gloves. Each glove was inverted and sealed immediately after collection.

Carcass Samples

A total of 124 carcass samples were collected by sterile sponge from each carcass 12 h after evisceration: a minimum of 100 cm2 from inside the round area from the navel–plate–brisket–foreshank areas. All carcass samples were collected according to the national regulations described in NOM-SSA1-1994 (15). All samples were placed in separate sterile plastic bags to prevent cross-contamination, labeled, and transported in ice to the laboratory.

Isolation and Identification of E. coli

Twenty-five grams of each sample was enriched by inoculation in 225 ml of peptone water. They were then homogenized and incubated at 37°C. After 24 h, the samples were plated onto eosin methylene blue and were incubated at 37°C for 18–24 h. Six colonies of presumptive E. coli strains were randomly picked from each sample, and each was subsequently transferred separately to tryptic soy agar and incubated for 24 h at 37°C to obtain a pure culture. All suspect colonies were confirmed by biochemical identification, including the sugar fermentation test, the indole production test, and the citrate test (16).

Antimicrobial Susceptibility Testing

Antimicrobial susceptibility was tested by the agar disc diffusion method, following the Clinical and Laboratory Standards Institute guidelines (17). The antimicrobials used were tetracycline (TE; 30 μg), ampicillin (AM; 10 μg), levofloxacin (LEV; 5 μg), cephalothin (CF; 30 μg), cefotaxime (30 μg), gentamicin (GE; 10 μg), cefepime (30 μg), trimethoprim/sulfamethoxazole (25 μg), netilmicin (NET, 30 μg), amikacin (30 μg), ceftriaxone (30 μg), and streptomycin (STR, 30 μg) (Sensi-disc BBL). These antimicrobials represent the major classes of antimicrobial drugs relevant in both veterinary and human medicine. Each E. coli strain colony was evaluated based on the diameter of the clear inhibition zone, and the results were interpreted following the criteria provided by the CLSI. E. coli ATCC 25922 was used as a control.

Antibiotic-Resistant Gene Detection

Bacterial DNA was obtained from a pure culture on tryptic soy agar (BD Becton Dickinson & Co., Cuautitlán Izcalli, Mexico) by lysis of a bacterial cell suspension at 95°C for 15 min, followed by centrifugation at 13,000 × g for 3 min. Six antibiotic resistance genes were screened by PCR: genes encoding tetracycline efflux pump (tetA and tetB), streptomycin phosphotransferases (strA), aminoglycoside adenyltransferase (aadA), and beta-lactamase resistance (blaTEM and blaSHV) (18–20). PCR conditions were performed in a total volume of 25 μl containing 1× buffer, 25 mM MgCl2, 10 mM dNTPs (Bioline), 10 mM of each primer, 5 U of Taq polymerase (Uniparts), and sterile water. PCR amplification was conducted following these conditions: initial denaturation at 95°C for 7 min, followed by 30 cycles of denaturation at 95°C for 45 s, annealing at 42 at 59°C for 45 s, and extension at 72°C for 45 s and a final cycle of amplification at 72°C for 7 min. The PCR products were analyzed by gel electrophoresis in 2.5% agarose (Sigma Aldrich, Germany), followed by visualization on a transilluminator.

Detection of Virulence Factors

The detection of virulence factor genes was performed according to the method described by Canizalez et al. (21). PCR was carried out using target gene-specific primers, including shiga toxin (stx1 and stx2), intimin (eaeA), bundle-forming pilus (bfp), and enterohemolysin A (hlyA). The PCR reaction mixture contained buffer 1X, MgCl2 25 mM, dNTPs 10 mM, primer 10 mM, and Taq DNA polymerase 5 U. The volume of this mix was adjusted to 25 μl with sterile water. The PCR amplification conditions were as follows: initial denaturation at 95°C for 1 min, followed by 30 cycles of denaturation at 95°C for 45 s, annealing at 54–60°C for 45 s, and extension at 72°C for 45 s and a final cycle of amplification at 72°C for 7 min. Verification of PCR products was performed in horizontal electrophoresis using 2.5% agarose gel with 0.5× TBE and Sybr gold at 100 V for 45 min. A molecular marker was run concurrently (100 pb Promega). The negative control consisted of all contents of the reaction mixture excluding template DNA, which was substituted with 1 μl sterile water. The DNA bands were visualized and photographed under UV light.

Results

Out of 248 samples tested, E. coli strains were detected in 85.9% (213/248); 87.9% (109/124) were confirmed as E. coli strains in fecal samples, and 83.8% (104/124) were from carcass samples (Table 1).
Table 1

Prevalence of phenotypical antimicrobial resistance in E. coli recovered from bovine feces and carcasses.

AntibioticBovine feces, n = 109 (%)Bovine carcasses, n = 104 (%)Total n = 213 (%)
Streptomycin44 (40.3)20 (19.2)64 (30.0)
Cefepime66 (60.5)066 (30.9)
Gentamicin17 (15.5)1 (0.9)18 (8.4)
Cefotaxime48 (44.0)1 (0.9)49 (23.0)
Trimethoprim/sulfamethoxazole41 (37.6)11 (10.5)52 (24.4)
Tetracycline78 (71.5)69 (66.3)147 (69.0)
Ampicillin75 (68.8)102 (98.0)177 (83.0)
Levofloxacin11 (10.0)2 (1.9)13 (6.1)
Cephalothin81 (74.3)81 (77.8)162 (76.0)
Netilmicin8 (7.3)8 (7.6)16 (7.5)
Amikacin13 (11.9)11 (10.5)24 (11.2)
Ceftriaxone33 (30.2)25 (24.0)58 (27.2)
Antimicrobial resistance to at least one antimicrobial99 (90.8)103 (99.0)202 (94.8)
Multidrug-resistant73 (66.9)82 (78.8)155 (72.7)
Prevalence of phenotypical antimicrobial resistance in E. coli recovered from bovine feces and carcasses. Among the 213 E. coli isolates tested, 94.8% (202/213) showed resistance for at least one antimicrobial, mainly AM (83.0%; 177/213), CF (76.0%; 162/213), and TE (69.0%; 147/213) (Table 1). The percentage of resistance to the other antimicrobial agents was in all cases below 36%. The results showed resistance to AM in 68.8% of fecal strains (75/109) and 98.0% of carcass strains (102/104). Phenotypic resistance to CF E. coli was confirmed in 74.3% of fecal isolates (81/109) and 77.8% of carcass isolates (81/104). The isolates that showed resistance to TE were 71.5% of fecal strains (78/109) and 66.3% of carcass strains (69/104). The percentage of sensitivity to LEV (90.6%; 193/213), GE (85.9%; 183/213), and NET (80.7%; 172/213) shown in this work was higher than 80%. Fifty-seven antibiogram resistance patterns were detected in this study (46 fecal and 11 carcasses; Table 2). The detection of 72.7% (155/213) strains which showed a MDR phenotype (104 fecal and 82 carcasses) is remarkable.
Table 2

Some resistance profiles of bovine feces and carcasses.

SampleNumber of antibioticsPatterns of resistance phenotypesIsolates
AMCFTESTRCROSTXCTXFEPAKNETGELEV
Bovine feces3AMCFSTR2
3AMCFCTX2
3CFTESTR3
3CFTEFEP2
4AMCFTESTR3
4AMTESTRCRO1
5AMCFTECROCTX2
5AMCFCROCTXFEP2
6AMCFTESTRCTXFEP2
6AMCFTESTRSTXCTX2
6AMCFCROSTXCTXFEP4
7AMCFTECROSTXCTXFEP3
7CFTESTRCROSTXCTXFEPNET2
8AMCFTESTRCROSTXCTXFEP3
Bovine carcasses3CFTECRO9
4TECRO2
5AMCFTECROSXT24
6AMTE2
6AMCFTESTRCROSXTAKGE6
6AMTELEV1
6AMCFTESTRCROSXTNET8
6AMCFTECROAK2
7AMCFTESTRCROSXTFEPAK2
7AMTESTRCROSXT3
7AMCFTECROCTXAKLEV1
Some resistance profiles of bovine feces and carcasses. Of the isolates, 19.2% (41/213) were negative for all the resistant genes tested. The tet(A) and tet(B) genes were detected in 43.1% of isolates (92/213; 35 fecal and 57 carcasses). Both tet genes were detected in 12.6% (27/213) of isolates (17 fecal and 10 carcasses). The strA and aadA1 genes were detected in 17.3% (37/213; eight fecal and 29 carcasses) and 51.6% (110/213; six fecal and 104 carcasses) of isolates, respectively. β-Lactamic genes were detected in 10.3% (22/213; 18 fecal and four carcasses) from blaTEM and in 0.4% (1/213; one fecal and zero carcasses) from blaSHV (Table 3).
Table 3

Distribution of resistance genes in Escherichia coli isolates from cattle.

Sample typesPrevalence of E. coliβ-Lactamic resistanceTetracycline resistanceStreptomycin resistance
PhenotypicGenotypicPhenotypicGenotypicPhenotypicGenotypic
AMCFblaTEMblaSHVTEtet (A)tet (B)STRstrAaadA-IV
Fecal10975/109 (68.8%)81/109 (74.3%)18/109 (16.5%)1/109 (0.9%)78/109 (71.5%)27/109 (24.7%)8/109 (7.3%)44/109 (40.3%)8/109 (7.3%)6/109 (5.5%)
Carcasses104102/104 (98.0%)81/104 (77.8%)4/104 (3.8%)0/104 (0%)69/104 (66.3%)29/104 (27.8%)28/104 (26.9%)20/104 (19.2%)29/104 (27.8%)104/104 (100%)
Total213177/213 (83.0%)162/213 (76.0%)22/213 (10.3%)1/213 (0.4%)147/213 (69.0%)56/213 (26.2%)36/213 (16.9%)64/213 (30.0%)37/213 (17.3%)110/213 (51.6%)
Distribution of resistance genes in Escherichia coli isolates from cattle. Of the isolates, 14.0% (30/213) showed one or two genes encoding a virulence factor (stx1, stx2, or hlyA). The stx genes were carried by 11.2% (24/213; 12 fecal and 12 carcasses) of the studied isolates. From these stx positives, 4.2% (9/213; three fecal and six carcasses) were stx1, and 7.0% (15/213; nine fecal and six carcasses) were stx2. Only three strains showed both genes stx1 and stx2 (1.4%; 3/213). However, hlyA was detected in only 2.8% (6/213; four fecal and two carcasses). None of the isolates contained the virulence genes eaeA and bfp.

Discussion

Previous studies show that antimicrobial resistance varies widely depending on the countries or animal from which the microorganisms have been isolated. In this study, E. coli strains with resistance to AM (83.0%), CF (76.0%), and TE (69.0%) were the most prevalent. Overall, other studies with E. coli strains from bovine samples showed a range of antimicrobial resistance to AM between 6.0 and 95.7% and to TE between 10.6 and 95% (8, 22–26). Globally, TE and AM are widely used in animal production, disease prevention, and growth promotion. Their combined resistance is often due to the colocation of different determinants in the same mobile genetic elements (plasmids, transposons, and/or integrons), and this has contributed to the selection of multidrug-resistant isolates worldwide (23). Fifty-seven antibiogram patterns of resistance were detected in this study (46 fecal and 11 carcasses) (Table 2). In the current study, an overall prevalence of MDR among the isolates (72.7%; Table 1) was high compared to previous studies worldwide, for example, an MDR of 44.4% in Egypt (27), 69.0% in Portugal (28), 56.0% in France (29), 13.7% in South Africa (30), and 37.1% in Jordan (24). In Mexico, an AMR study in the northwest reported an MDR of 42% (14). This might be due to inappropriate or excessive use of antibiotics for therapeutic and prophylactic treatment (31, 32). These results suggest that bovines may represent an important reservoir of antibiotic-resistant bacteria, be a route of spread, and represent a health risk. Of the 147 E. coli strains with phenotypic resistance to TE, 38.0% (56/147) showed the gene tetA and 24.4% (36/147) the gene tetB. While the tetA gene had a similar prevalence in both types of samples (fecal, 27/109 and carcasses, 29/104) for the tetB gene, the prevalence was markedly higher in carcass samples compared to that in fecal samples (fecal, 8/109 and carcasses, 28/104). Of the 64 strains with phenotypic resistance to STR, 57.8% (37/64) have the resistance gene strA and 100% (64/64) the resistance gene aadA-IV. The 46 strains identified with the aadA-IV gene did not show phenotypic resistance to STR (Table 3). These resistance genes may be transferable from E. coli to other bacteria in the gut and subsequently disseminated into the environment. The virulence factors of E. coli strains were frequently associated with MDR. In the association between antimicrobial resistance and virulence factors, the most remarkable was resistance to AM, CF, TE, and STR in all strains with stx1 virulence factors (9/9); 100% (15/15) of strains stx2 showed resistance to at least one antimicrobial. Of these, 40% (6/15) showed resistance to four. One strain harboring hlyA was not resistant to any antibiotic tested (6.6%; 1/15), and the rest of the hlyA-harboring strains had antimicrobial resistance to two or more antibiotics (93.3%; 14/15). E. coli harboring stx and eae genes might represent a high zoonotic risk, as these genes are often found in human pathogenic enterohemorrhagic E. coli strains (26, 33, 34). In this study, the stx genes and the hlyA gene were present in our isolates, whereas aea and bfp were not detected. The gene stx2 codes for a potent toxin, often associated with the development of hemorrhagic colitis and hemolytic uremic syndrome in humans and was frequently associated with more severe human diseases than stx1 (26, 35).

Conclusions

In this study, we detected a high prevalence of E. coli strains with resistance (82.0%) and MDR (72.7%) with AM, CF, and TE being the least effective antibiotics. Although the prevalence of virulence factors was low, the strains harboring the virulence factors were frequently associated with MDR. These results suggest that bovines may represent an important reservoir of antibiotic-resistant bacteria and show the need to enforce the regulations in the use of antimicrobials in food-producing animals.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Author Contributions

AM-V and JV-V participated in samples processing and laboratory analysis. LL-Z participated in samples acquisition and processing. HB-G and GR participated in data analysis and first draft. VB-G participated in study design and revised and approved the final manuscript. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  28 in total

1.  Foodborne Outbreaks Reported to the U.S. Food Safety and Inspection Service, Fiscal Years 2007 through 2012.

Authors:  Kis Robertson; Alice Green; Latasha Allen; Timothy Ihry; Patricia White; Wu-San Chen; Aphrodite Douris; Jeoffrey Levine
Journal:  J Food Prot       Date:  2016-03       Impact factor: 2.077

2.  Escherichia coli Population Structure and Antibiotic Resistance at a Buffalo/Cattle Interface in Southern Africa.

Authors:  Mathilde Mercat; Olivier Clermont; Méril Massot; Etienne Ruppe; Michel de Garine-Wichatitsky; Eve Miguel; Hugo Valls Fox; Daniel Cornelis; Antoine Andremont; Erick Denamur; Alexandre Caron
Journal:  Appl Environ Microbiol       Date:  2015-12-28       Impact factor: 4.792

Review 3.  Antibiotic resistance in Escherichia coli in husbandry animals: the African perspective.

Authors:  C A Alonso; M Zarazaga; R Ben Sallem; A Jouini; K Ben Slama; C Torres
Journal:  Lett Appl Microbiol       Date:  2017-05       Impact factor: 2.858

Review 4.  Pet animals as reservoirs of antimicrobial-resistant bacteria.

Authors:  Luca Guardabassi; Stefan Schwarz; David H Lloyd
Journal:  J Antimicrob Chemother       Date:  2004-07-14       Impact factor: 5.790

5.  Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins.

Authors:  Yolanda Sáenz; Laura Briñas; Elena Domínguez; Joaquim Ruiz; Myriam Zarazaga; Jordi Vila; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Prevalence of Antibiotic Resistance Genes in Multidrug-Resistant Enterobacteriaceae on Portuguese Livestock Manure.

Authors:  Paula Amador; Ruben Fernandes; Cristina Prudêncio; Isabel Duarte
Journal:  Antibiotics (Basel)       Date:  2019-03-13

7.  Co-resistance to Amoxicillin and Tetracycline as an Indicator of Multidrug Resistance in Escherichia coli Isolates From Animals.

Authors:  Clémence Bourély; Géraldine Cazeau; Nathalie Jarrige; Eric Jouy; Marisa Haenni; Agnese Lupo; Jean-Yves Madec; Agnès Leblond; Emilie Gay
Journal:  Front Microbiol       Date:  2019-10-09       Impact factor: 5.640

8.  Characterization of Non-O157 Escherichia coli from Cattle Faecal Samples in the North-West Province of South Africa.

Authors:  Emmanuel W Bumunang; Tim A McAllister; Rahat Zaheer; Rodrigo Ortega Polo; Kim Stanford; Robin King; Yan D Niu; Collins N Ateba
Journal:  Microorganisms       Date:  2019-08-20

9.  Antimicrobial resistance profiles of Shiga toxin-producing Escherichia coli O157 and Non-O157 recovered from domestic farm animals in rural communities in Northwestern Mexico.

Authors:  Bianca A Amézquita-López; Beatriz Quiñones; Marcela Soto-Beltrán; Bertram G Lee; Jaszemyn C Yambao; Ofelia Y Lugo-Melchor; Cristóbal Chaidez
Journal:  Antimicrob Resist Infect Control       Date:  2016-01-05       Impact factor: 4.887

10.  Antimicrobial Resistance in Escherichia coli Recovered from Feedlot Cattle and Associations with Antimicrobial Use.

Authors:  Katharine M Benedict; Sheryl P Gow; Tim A McAllister; Calvin W Booker; Sherry J Hannon; Sylvia L Checkley; Noelle R Noyes; Paul S Morley
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more
  3 in total

1.  New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036.

Authors:  Fuhang Song; Yifei Dong; Shangzhu Wei; Xinwan Zhang; Kai Zhang; Xiuli Xu
Journal:  Antibiotics (Basel)       Date:  2022-02-10

2.  Development of multidrug-resistant Escherichia coli in some Egyptian veterinary farms.

Authors:  A A Samy; Asmaa S Mansour; Doaa D Khalaf; Eman A Khairy
Journal:  Vet World       Date:  2022-02-27

3.  Pathogenic E. coli from Cattle as a Reservoir of Resistance Genes to Various Groups of Antibiotics.

Authors:  Alexandra Tabaran; Virginie Soulageon; Flore Chirila; Oana Lucia Reget; Marian Mihaiu; Mihai Borzan; Sorin Daniel Dan
Journal:  Antibiotics (Basel)       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.